AUGUST 2019
 
 
Rendering of Nexus Pharmaceuticals facility being built in Pleasant Prairie
 
 

A rendering of Nexus Pharmaceuticals’ planned manufacturing facility (Credit: Integrated Project Services)

 
 

Nexus Pharmaceuticals to build its first production facility in Pleasant Prairie

 
 

Nexus Pharmaceuticals has chosen Pleasant Prairie as the location of its first sterile injectable drug production facility. The new $85 million operation will support the company’s specialty and generic drug production, much of which is currently contracted out to third-party manufacturers in Europe.

Nexus, a woman-owned, privately held company based in Lincolnshire, Illinois, produces injectable drugs for therapeutic use in anesthesia, oncology, neurology and cardiovascular applications. The Pleasant Prairie project is expected to create 77 jobs in high-tech production, analytical testing, engineering, quality control and supply chain management.

“We are looking forward to executing the next phase of our growth plan in Wisconsin," said Nexus CEO Mariam Darsot. “The addition of our Wisconsin facility will enable Nexus to produce a more stable and reliable supply of sterile injectables, a category that is particularly susceptible to drug shortages.”

Nexus plans a multi-phase project with a total investment of $250 million over 10 years. Construction on the 100,000-square-foot production facility, the project’s first phase, begins next month. The company expects construction to be complete in 2021 and production to start in 2022 after all regulatory approvals are secured.

WEDC is supporting the project with up to $1.5 million in state income tax credits over the next four years. The actual amount of tax credits Nexus will receive is contingent upon the number of jobs created and the amount of capital investment during that period.

 
 
 
 
 
 
 

mary-perry.pngJoin other Wisconsin companies in a location that offers diversity to start, grow or expand your business. For more information about opportunities in Wisconsin, contact me at 608.210.6740 or mary.perry@wedc.org, or visit InWisconsin.com.

Mary Perry, Business and Investment Attraction Director

 
 
You might be interested in our other newsletters.

From practical information for expanding to international markets to best practices for downtown and community development, WEDC offers six email newsletters to keep you informed of the latest economic development news in Wisconsin.
 
 
facebook   linkedin   twitter   instagram   youtube   mail
 
 
This message sent by:
Wisconsin Economic Development Corporation
201 W. Washington Avenue, Madison, WI 53703